This page is free to read, and it stops after 5 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and what each filing says: its issues, the agencies contacted and the lobbyists named, is part of the subscription. So is sorting the list by the reported amount. What that costs is on the pricing page.

Lobbying reported per quarter

reported amounts per quarter, latest version of each report

Before 2025, these bars cover only the lobbying relationships that were still active in 2025 or later. Engagements that ended earlier are not included, so those years may be higher than shown.

There are two charts here because there are two different amounts. A lobbying firm reports income: what it was paid. A company that lobbies for itself reports expenses: what it spent, under one of three accounting methods it picks itself. Both appear under this company, and they are not the same measurement — so they are never added, not in a bar and not in a total.

Reported income

what lobbying firms reported receiving from this company's clients, per quarter

Q1Q4
$0$50k$100k2024: $0 Q1, $88k Q420242025: $0 Q1, $0 Q42025

Reported expenses

what this company reported spending on its own lobbying, per quarter, under the accounting method it picked itself

Q1Q4
$0$100k$200k2024: $0 Q1, $100k Q420242025: $160k Q1, $0 Q42025

Recent activity

5 filings

The most recently posted lobbying filings for TVTX
RegistrantFilingAmountPosted Source
TRAVERE THERAPEUTICSfor TRAVERE THERAPEUTICS1st Quarter - Report1st Quarter 2025$160,000expenses (A)posted Apr 16, 2025Apr 16, 2025LD-2 at lda.gov
THE HEALTH EQUITY STRATEGIES GROUP, LLCfor TRAVERE THERAPEUTICS4th Quarter - Report4th Quarter 2024$15,500incomeposted Feb 4, 2025Feb 4, 2025LD-2 at lda.gov
TRAVERE THERAPEUTICSfor TRAVERE THERAPEUTICS4th Quarter - Report4th Quarter 2024$100,000expenses (A)posted Feb 4, 2025Feb 4, 2025LD-2 at lda.gov
ALSTON & BIRD LLPfor TRAVERE THERAPEUTICS4th Quarter - Report4th Quarter 2024$60,000incomeposted Jan 21, 2025Jan 21, 2025LD-2 at lda.gov
2359 STRATEGIESfor TRAVERE THERAPEUTICS4th Quarter - Report4th Quarter 2024$12,000incomeposted Jan 21, 2025Jan 21, 2025LD-2 at lda.gov